REGENXBIO Inc. (RGNX) Capital expenditures 2016–2025
REGENXBIO Inc. (RGNX) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$2.4MFY2025 · since FY2016: $8.1M → $2.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $2.4M | -0.9% |
| FY2024 | $2.4M | -75.5% |
| FY2023 | $10.0M | -67.6% |
| FY2022 | $30.7M | -63.5% |
| FY2021 | $84.2M | +213.3% |
| FY2020 | $26.9M | +129.3% |
| FY2019 | $11.7M | -11.7% |
| FY2018 | $13.3M | +85.4% |
| FY2017 | $7.2M | -12.1% |
| FY2016 | $8.1M | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice